Description
Category: Technology Licenses
Created On: 2022-04-28
Record Count: 3
Primary Industries
- Drugs
- Cancer
- Pharmaceuticals
IPSCIO Report Record List
Below you will find the records curated into this collection. This summary includes the complete licensed property description so that you can review and determine if this collection covers the topics, technology or transaction type that is relevant for your needs. The full report will include all relevant deal data such as the royalty base, agreement date, term description, royalty rates and other deal terms. For reference, here is a sample of a full IPSCIO curated royalty rate report: Sample Report
IPSCIO Record ID: 27843
STS is currently marketed for use in humans as part of a treatment for cyanide poisoning. The Licensee has Licensed intellectual property rights for the use of STS as a chemoprotectant, and are developing STS as a protectant against the hearing loss often caused by platinum-based anti-cancer agents, in both children and adults. We have received Orphan Drug Designation in the United States for the use of STS in the prevention of platinum-induced ototoxicity in pediatric patients.
Licensed Patent or Patent Applications
Item
Patent
Application
Serial
Country
Title
Inventors
Filing
Issue Date
Current
Uni Ref
#
No
No.
No.
Date
Status
No.
1
5124146
644331
N/A
US
Differential delivery of therapeutic agents across the blood brain barrier
Neuwelt
33260
33778
Published
OHSU #120
Int’l
2
N/A
N/A
PCT/US01/40624
US
Administration of a thiol based chemoprotectant compount
Neuwelt
36642
N/A
Nationalization due 26 Oct 2002 Draft of claims written to be filed Oct 16
OHSU
WO 01/80832
Int’l
# 493
60/199,936
60/229/870
2 a)
N/A
N/A
60/229,870
Provisional
Chemoprotectant compounds for protection against organ damage
Neuwelt
36768
N/A
Pending
OHSU
Muldoon
#493 continued
2 b)
N/A
N/A
60/199,936
Provisional
Localised administration of a thiol based chemoprotectant compount against myelosuppression
Newwelt
36642
N/A
Pending
OHSU
Muldoon
#493
Pagel
continued
3
N/A
N/A
PCT/USO1/27296
US
Chemoprotectant for gastric toxicity
Neuwelt
36768
N/A
Nationalization due Feb 28, 2003
OHSU
60/229,869
Int’l
Muldoon
# 512
3 a)
N/A
N/A
60/229,869
Provisional
Chemoprotectant for gastric toxicity
Neuwelt
36768
N/A
Pending
OHSU
Muldoon
# 512
4
N/A
N/A
In progress
Provisional
Prevention of mucositis and related diseases along the GI tract
Neuwelt
In progress
N/A
In progress
493-B
5
N/A
N/A
Pending
Provisional
Administration of NAC to diminish infarction volume
Neuwelt
37519
N/A
Pending
493-A
6
4800042
122027
07/122,027
US
Method for the delivery of genetic material across the blood brain barrier
Neuwelt
32099
32763
Published
OHSU
Int’l
# 121
7
5059415
314940
07/314,940
US
Method for diagnostically imaging lesions in the brain inside a blood brain barrier
Newwelt
32560
33533
Published
OHSU
Int’l
# 131
The present invention generally relates to a method for delivering therapeutic agents into the brain, and more specifically to such a method in which the therapeutic agents are delivered across the blood brain barrier.
5,124,146 A method for the delivery of therapeutic agents across the blood brain barrier is disclosed which utilizes drug neutralization technology, and the selective permeability o This invention was made with support by the Preuss Foundation and with Government support by the Veterans Administration and under Grant No. 31770 awarded by the National Institutes of Health. The Government has certain rights in this invention.
IPSCIO Record ID: 7467
IPSCIO Record ID: 5499
The transaction assigned rights to a family of molecules designated as Receptor-Mediated Permeabilizers(TM) (RMPs(TM)), including Cereport.
